RE:Liabilityto lonc17. I agree that he might be on thin ice if it is a bust. I do not think it is a bust. I do not think the share price is related to mBC being a bust. More likely a lack of clarity. We have AN without a CPI. We have MC stating at one point that AN might go with a CPI and then again they might not. The Roche mBC trial has never been crystal clear to me. The Pfizer/Merck trial with that annoying 90 day clause is is akin to a gordian knot; that is to say a jumble. One can only hope this can be untied.
As to AA I guess that would be more likely to go to GOBLET, I am wondering how they could apply for AA for pela without Roche and tecentriq. If they have gone ahead with Roche, we would seem to have something solid.
Perhaps a knowledgeable shareholder can give some clarity to AA, and the mBC trials.
Must run MTG is on.